Science and Technology Committee

À propos

Subject: Innovation in the NHS: personalised medicine and AI Witness(es): Matthew Durdy, CEO, Cell and Gene Therapy Catapult; Chris Molloy, CEO, Medicines Discovery Catapult Witness(es): Professor Anneke Lucassen